title: Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?
authors.forename: Lisa
authors.initials: L
authors.lastname: Licitra
authors.forename: Paolo
authors.initials: P
authors.lastname: Bossi
authors.forename: Laura
authors.initials: L
authors.lastname: Locati
authors.forename: Franco
authors.initials: F
authors.lastname: Zunino
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage / Q000493:pharmacokinetics; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000008:administration & dosage / Q000493:pharmacokinetics; D006801:Humans; D007262:Infusions, Intravenous; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*
chemical_list: D002945:Cisplatin; D005472:Fluorouracil